Daily FNArena News

As predicted, the Q1 update is pulling expectations lower. But should the share price not go up from here?

Although most brokers see little benefit arising from the Zenyth acquisition over the short term, CSL remains one of the highest rated stocks in Australia.

Has the short-lived hype opened the door to litigation? Lawyers, bourse authorities and the corporate regulator are all looking into the matter of CuDeco.

China is expected to report quarterly GDP growth of more than 10% today, leading an increasing number of experts to argue higher interest rates will be needed to curb the growth rate.

The uranium market in a lot of ways mirrors the metals markets – increasing demand and tardy supply. Brokers are becoming more convinced of a tight market for some time to come. How best to invest in such an environment?

A clarification by the company on its latest drilling results and estimates has caused the share price to halve again.

NAB and CommSec had been holding out in the “no more 2006 rate rises” camp, but the story has changed. CommSec capitulated last week, and NAB has followed today.

Stephen Koukoulas from TD Securities suggests there is now no chance of a rate cut in New Zealand in 2006, with a further increase possible as inflation continues to strengthen.

Westpac has become the cheapest bank on Merrill Lynch’s valuation screens. Longer term the broker still prefers St George.

Sonic Healthcare (SHL) has lost a key contract in New Zealand, but brokers remain positive on the outlook for the group as the key to its growth remains Europe and the US.